DarioHealth Corp. (DRIO) › Cash & EquivalentsDarioHealth Corp. (DRIO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2011-08-10: $02011-12-31: $908.8K2012-12-31: $1.23M2013-12-31: $2.26M2014-12-31: $1.45M2015-12-31: $2.67M2016-12-31: $1.09M2017-12-31: $3.72M2018-12-31: $11.00M2019-12-31: $20.39M2020-12-31: $28.59M2021-12-31: $35.81M2022-12-31: $49.36M2023-12-31: $36.80M2024-12-31: $27.76M2025-12-31: $21.80M$21.80M2011-08-10Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$21.80M-21.5%2026-03-19Balance as of period end2024-12-31$27.76M-24.5%2026-03-19Balance as of period end2023-12-31$36.80M-25.4%2025-03-10Balance as of period end2022-12-31$49.36M+37.8%2024-03-28Balance as of period end2021-12-31$35.81M+25.2%2023-03-09Balance as of period end2020-12-31$28.59M+40.2%2022-03-22Balance as of period end2019-12-31$20.39M+85.5%2021-03-09Balance as of period end2018-12-31$11.00M+195.8%2020-03-17Balance as of period end2017-12-31$3.72M+240.2%2019-03-25Balance as of period end2016-12-31$1.09M-59.1%2019-03-25Balance as of period end2015-12-31$2.67M+83.8%2018-03-19Balance as of period end2014-12-31$1.45M-35.8%2017-03-22Balance as of period end2013-12-31$2.26M+84.0%2016-02-08Balance as of period end2012-12-31$1.23M+35.3%2015-03-24Balance as of period end2011-12-31$908.8K—2014-03-04Balance as of period end2011-08-10$0—2014-03-04Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)